Skip to search formSkip to main contentSkip to account menu

MPV 295

Known as: MPV-295 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Radioimmunoassay for MPV-295, a new antihypertensive drug.
A specific and simple radioimmunoassay for the determination of MPV-295, 4(5)-[2-(2,6-dimethylphenyl)-ethyl]imidazole, in human… 
1984
1984
The immediate haemodynamic effects of MPV 295 (4(5)-2-(2,6-dimethylphenyl)ethylimidazole), a new vasoactive agent with alpha-adrenoceptor agonistic properties, in the anaesthetized dog.
We have evaluated the immediate (0-30 min) circulatory effects of an i.v. bolus of a new compound, MPV 295, an imidazole… 
1983
1983
The cardiovascular effects of MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole], a new antihypertensive agent with α2-adrenoceptor agonistic properties
SummaryThe cardiovascular effects of a new compound MPV 295 [4(5)-2-(2,6-dimethylphenyl)ethylimidazole] were studied in both… 
1983
1983
A comparative study on hypotensive and bradycardic effects of some new imidazole derivatives with possible central mechanism of action.
Cardiovascular actions of 4(5)-(2,6-dimethylbenzyl)imidazole (MPV-207) and its three alkyl bridge analogues were investigated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)